Healthy volunteers needed to test how food affects new drug EB-1020
NCT ID NCT01744808
First seen Apr 23, 2026 · Last updated May 22, 2026 · Updated 9 times
Summary
This early-stage study tested a new drug called EB-1020 in 54 healthy adults aged 18-45. The main goals were to see if taking the drug with food changes how the body absorbs it, and to check the drug's safety and tolerability at different doses. Participants received the drug in various forms and doses, and researchers measured drug levels in the blood and monitored for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NORMAL, HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network Ltd.
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.